La Jolla Pharmaceutical Stock Current Valuation
| LJPCDelisted Stock | USD 6.22 0.00 0.00% |
Valuation analysis of La Jolla Pharmaceutical helps investors to measure La Jolla's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that La Jolla's price fluctuation is very steady at this time. Calculation of the real value of La Jolla Pharmaceutical is based on 3 months time horizon. Increasing La Jolla's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for La Jolla Pharmaceutical is useful when determining the fair value of the LJPC stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of La Jolla. Since La Jolla is currently traded on the exchange, buyers and sellers on that exchange determine the market value of LJPC Stock. However, La Jolla's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 6.22 | Real 4.63 | Hype 6.22 | Naive 7.06 |
The real value of LJPC Stock, also known as its intrinsic value, is the underlying worth of La Jolla Pharmaceutical Company, which is reflected in its stock price. It is based on La Jolla's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of La Jolla's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence La Jolla's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of La Jolla Pharmaceutical helps investors to forecast how LJPC stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of La Jolla more accurately as focusing exclusively on La Jolla's fundamentals will not take into account other important factors: La Jolla Pharmaceutical Company Current Valuation Analysis
La Jolla's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current La Jolla Current Valuation | 242.85 M |
Most of La Jolla's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, La Jolla Pharmaceutical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, La Jolla Pharmaceutical has a Current Valuation of 242.85 M. This is 98.31% lower than that of the Healthcare sector and 94.77% lower than that of the Biotechnology industry. The current valuation for all United States stocks is 98.54% higher than that of the company.
LJPC Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses La Jolla's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of La Jolla could also be used in its relative valuation, which is a method of valuing La Jolla by comparing valuation metrics of similar companies.La Jolla is currently under evaluation in current valuation category among related companies.
LJPC Fundamentals
| Return On Equity | 0.0544 | |||
| Return On Asset | 1.64 | |||
| Profit Margin | 10.08 % | |||
| Operating Margin | 4.68 % | |||
| Current Valuation | 242.85 M | |||
| Shares Outstanding | 27.52 M | |||
| Shares Owned By Insiders | 1.91 % | |||
| Shares Owned By Institutions | 71.79 % | |||
| Number Of Shares Shorted | 202.51 K | |||
| Price To Earning | 38.88 X | |||
| Price To Book | 30.11 X | |||
| Price To Sales | 3.29 X | |||
| Revenue | 52.01 M | |||
| Gross Profit | 63.08 M | |||
| EBITDA | 4.09 M | |||
| Net Income | 5.24 M | |||
| Cash And Equivalents | 44.56 M | |||
| Cash Per Share | 1.74 X | |||
| Total Debt | 124.8 M | |||
| Debt To Equity | 7.16 % | |||
| Current Ratio | 3.92 X | |||
| Book Value Per Share | (3.36) X | |||
| Cash Flow From Operations | 13.59 M | |||
| Short Ratio | 0.46 X | |||
| Earnings Per Share | (1.44) X | |||
| Price To Earnings To Growth | 11.72 X | |||
| Number Of Employees | 61 | |||
| Beta | 1.97 | |||
| Market Capitalization | 171.2 M | |||
| Total Asset | 89.52 M | |||
| Retained Earnings | (1.06 B) | |||
| Working Capital | 79.5 M | |||
| Current Asset | 86.74 M | |||
| Current Liabilities | 7.24 M | |||
| Z Score | -14.8 |
About La Jolla Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze La Jolla Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of La Jolla using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of La Jolla Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Consideration for investing in LJPC Stock
If you are still planning to invest in La Jolla Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the La Jolla's history and understand the potential risks before investing.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |